This is the third and final part of MedicinMan interview with Sunil Attavar, CMD, Group Pharma and President, KDPMA
MedicinMan: Are there any estimates of what the overall business impact will be in terms of revenues of pharma companies?
 At this moment it is very difficult to estimate the impact but it will not be uniform across companies.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
